
Pharm. Roland Addo-Hammond is a seasoned pharmaceutical executive and global health leader with over twenty years of experience in the life sciences industry. His career spans various leadership roles in clinical development, medical affairs, market access, policy, and external engagement across diverse geographies including Sub-Saharan Africa, Europe, the Middle East, and Canada. With a strong foundation in pharmacy and a doctorate in pharmacology, he has applied his scientific expertise to strategic leadership, driving patient access, health system strengthening, and cross-sectoral partnerships.
At Novartis, he has led initiatives that integrate patient-focused strategies into product development and commercialization, including in the area of sickle cell disease where he has played a central role in advancing public-private collaborations with governments and global stakeholders. His work has supported regulatory submissions, access frameworks, and the delivery of innovative therapies in underserved markets. He has also held critical responsibilities in shaping policy engagement and external affairs for the company’s Global Health Unit.
Pharm. Addo-Hammond brings a proven track record in designing and executing multi-country programs aimed at improving healthcare outcomes, with a focus on sustainability, equity, and measurable impact. His contributions span disease areas such as malaria, cardiovascular disease, oncology, and non-communicable diseases. He continues to advocate for patient-centered approaches and scalable health innovations, combining scientific knowledge, policy insight, and operational excellence to influence global health priorities and pharmaceutical access strategies.
Enhancing Sickle Cell Care – The Role of the Pharmacist |